quick search
Today:
Home Finance

More Articles

Tuya Reports Fourth Quarter and Fiscal 2024 Unaudited Financial Results and Declaration of Dividend

Feb 27, 2025

SANTA CLARA,Calif.,Feb. 26,2025-- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391),a global leading AI cloud platform service provider,today announced its unaudited fin

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs

Feb 26, 2025

HONG KONG,Feb. 25,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab,Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a c

ATFX Illuminates the Future with 2025 Annual Gala Dinner

Feb 26, 2025

KUALA LUMPUR,Malaysia,Feb. 25,2025-- On February 22,2025,ATFX hosted its highly anticipated Gala Dinner at the prestigious Shangri-La Hotel in Kuala Lumpur,bringing together over 600 employees from 23

ATRenew to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Feb 26, 2025

SHANGHAI,Feb. 25,2025-- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE),a leading technology-driven pre-owned consumer electronics transactions and services platform in Chin

Emirates to hold its first ever pilot recruitment roadshow in Macao

Feb 26, 2025

DUBAI,UAE,Feb. 25,2025-- Emirates,as the international airline based in Dubai,has announced its first series of pilot recruitment roadshows in Macao Special Administrative Region,China to meet the str

Paris Baguette Expands Global Reach with the Launch of Its Regional Manufacturing Hub in Johor, Malaysia

Feb 26, 2025

Strategic Growth to Strengthen International Supply Chain and Meet Rising Global Demand JOHOR BAHRU,Malaysia,Feb. 25,2025-- Paris Baguette,the globally renowned bakery brand under SPC Group,has offici

CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China

Feb 26, 2025

SHANGHAI,Feb. 25,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK,"CARsgen Therapeutics"),a company focused on innovative CAR T-cell therapies for the treatment of hematolo

Vialto Partners Completes Recapitalization Transaction

Feb 26, 2025

Transaction Completely and Definitively Transforms Vialto\'s Capital Structure,Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of

e& delivers record revenue and net profit in FY 2024 growing consolidated revenue 10.1% to AED 59.2 billion

Feb 26, 2025

Net profit reached AED 10.8 billion,growing 4.3 per cent year-over-year Full year dividend per share of 83 fils

Michter's Announces 2025 Release of Its US*1 Barrel Strength Rye

Feb 26, 2025

LOUISVILLE,Ky.,Feb. 25,2025--Michter\'s Master Distiller Dan McKee and Michter\'s Master of Maturation Andrea Wilson have approved the release of Michter\'s US*1 Barrel Strength Rye. Shipments to bar

1 ... 23 24 25 26 27 28 29 ... 131

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs